Pfizer pays $179m for Brisbane company behind smartphone app that claims to diagnose COVID


A Brisbane-based company that invented a smartphone app it says can diagnose COVID-19 and other respiratory illnesses by listening to someone cough has been purchased by Pfizer for nearly $180 million.

ResApp Health Limited uses diagnostic technology developed by Associate Professor Udantha Abeyratne and his research team at the University of Queensland (UQ) to record and analyse a patient's coughs on a smartphone.

The app also considers the self-reporting of simple symptoms like a runny nose or fever to diagnose and measure the severity of a range of pulmonary diseases, including asthma and pneumonia.

Read More: https://www.abc.net.au/news/2022-09-28/qld-pfizer-buys-uq-start-upresapp-health-covid/101478832



Comments

Popular posts from this blog

Simple Ways to Pet-Proof Your New Home While Moving

How To Clean Upholstery With Steam Cleaner

Former Logan mayor Luke Smith gets suspended sentence after admitting to secret commissions and misconduct